Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-11-20
2007-11-20
Angell, Jon E. (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S024500, C514S04400A
Reexamination Certificate
active
10537001
ABSTRACT:
The present invention provides an agent for inhibiting metastasis of colorectal cancer and a method for inhibiting metastasis of colorectal cancer, which inhibit the function of Asef (i.e., binding activity to the APC gene product or guanine nucleotide exchange factor activity) that binds to the gene product of the tumor suppressor gene APC that plays an important role in tumorigenesis and in developmental processes, and/or inhibit the expression of the Asef gene.
REFERENCES:
patent: 6506559 (2003-01-01), Fire et al.
patent: 2003/0073623 (2003-04-01), Drmanac et al.
patent: 2003/0157531 (2003-08-01), Costa et al.
patent: 2001-57888 (2001-06-01), None
Senda et al., The tumor suppressor protein APC colocalizes with b-catenin in the colon epithelial cells, 1996, Biochemical & Biophysical Research Communications, vol. 223, pp. 329-334.
Opalinska et al., Nucleic-acid therapeutics: Basic principles and recent applications, Jul. 2002, Nature Reviews Drug Discovery, vol. 1, pp. 503-514.
Patil et al., DNA-based therapeutics and DNA delivery systems: A comprehensive reivew, 2005, The AAPS Journal, vol. 7, pp. E61-E77.
Kawasaki et al., “Mutated APC and Asef are Involved in the Migration of Colorectal Tumor Cells,” Nature Cell Biology, vol. 5, Mar. 2003 (pp. 211-215).
Jimbo et al., “A New Stage of a Study of APC Protein,” Molecular Medicine, vol. 39, No. 11, 2002 (pp. 1274-1279) (with partial English translation).
Akiyama, “The Tumor Suppressor Gene Product APC and Asef,” Journal of Clinical and Experimental Medicine, vol. 205, No. 13, 2003 (p. 1001) (with partial English translation).
Kawasaki et al., “A Mutated APC/Asef Complex is Involved in Motility of Cololectal Cancer Cells,” Supplement of Japanese Journal of Cancer Research, No. 3048, vol. 61, 2002 (p. 111) (with partial English translation).
Kawasaki et al., “Asef, a Link Between the Tumor Suppressor APC and G-Protein Signaling,” SCIENCE, vol. 289, Aug. 18, 2000 (pp. 1194-1197).
Kawasaki et al., “A Novel Function of the Tumor Suppressor Gene Product APC,” Protein, Nucleic Acid and Enzyme, vol. 46, No. 3, 2001 (pp. 228-232) (with partial English translation).
Senda, “APC Tumor Suppressor Gene—Diversity of its Expression and Functions,” Jpn. J. Clin. Electron Microsc., vol. 33, No. 2, 2001 (pp. 65-74) (with partial English translation).
Paddison et al., “Short Hairpin RNAs (shRNAs) Induce Sequence-Specific Silencing in Mammalian Cells,” Genes & Development, vol. 16, No. 8, 2002 (pp. 948-958).
Jenuwein, “An RNA-Guided Pathway for the Epigenome,” SCIENCE, vol. 297, Sep. 27, 2002 (pp. 2215-2218).
Kinzler et al., “Lessons from Hereditary Colorectal Cancer,” CELL, vol. 87, Oct. 18, 1996 (pp. 159-170).
Fearnhead et al., “The ABC of APC,” Human Molecular Genetics, vol. 10, No. 7, 2001 (pp. 721-733).
Bienz et al., “Linking Colorectal Cancer to Wnt Signaling,” CELL, vol. 103, Oct. 13, 2000 (pp. 311-320).
Peifer et al., “Wnt Signaling in Oncogenesis and Embryogenesis—A Look Outside the Nucleus,” SCIENCE, vol. 287, Mar. 3, 2000 (pp. 1606-1609).
Akiyama, “Wnt/β-Catenin Signaling,” Cytokine & Growth Factor Reviews, vol. 11, 2000 (pp. 273-282).
Miyoshi et al., “Somatic Mutations of the APC Gene in Colorectal Tumors: Mutation Cluster Region in the APC Gene,” Human Molecular Genetics, vol. 1, No. 4, 1992 (pp. 229-233).
Nagase et al., “Mutations of the APC (Adenomatous Polyposis Coli) Gene,” Human Mutation, vol. 2, 1993 (pp. 425-434).
Molenaar et al., “XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos,” Cell, vol. 86, Aug. 9, 1996 (pp. 391-399).
Behrens et al., “Functional Interaction of β-Catenin With the Transcription Factor LEF-1,” NATURE, vol. 382, Aug. 15, 1996 (pp. 638-642).
Wong et al., “Forced Expression of the Tumor Suppressor Adenomatosis Polyposis Coli Protein Induces Disordered Cell Migration in the Intestinal Epithelium,” Proc. Natl. Acad. Sci, USA, vol. 93, Sep. 1996 (pp. 9588-9593).
Oshima et al., “Morphological and Molecular Processes of Polyp Formation in ApcΔ716Knockout Mice,” Cancer Research, vol. 57, May 1, 1997 (pp. 1644-1649).
International Search Report for PCT/JP03/10449 dated Dec. 2, 2003.
Translation of International Preliminary Report on Patentability for PCT/JP2003/010449 dated Sep. 29, 2005.
Akiyama Tetsu
Esashi Rina
Kawasaki Yoshihiro
Angell Jon E.
Daiichi Pharmaceutical Co. Ltd.
Kilyk & Bowersox P.L.L.C.
Shin Dana
LandOfFree
Colon cancer metastasis inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Colon cancer metastasis inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Colon cancer metastasis inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3884427